Denali Therapeutics Inc. (DNLI) Current Reports & Earnings Releases
Upcoming
- 2026-11-05 Earnings Release Estimated
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-08-06 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-07-28 | 8-K | Acquisition or Disposition, Financial Statements & Exhibits | SEC |
| 2026-06-18 | 8-K | Material Agreement, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-06-04 | 8-K | Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2026-05-22 | 8-K | Reg FD Disclosure | SEC |
| 2026-05-07 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-04-03 | 8-K | Termination of Agreement, Financial Statements & Exhibits | SEC |
| 2026-03-31 | 8-K | Direct Financial Obligation, Reg FD Disclosure | SEC |
| 2026-03-25 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-02-26 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-01-06 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-12-10 | 8-K | Material Agreement, Other Events, Financial Statements & Exhibits | SEC |
| 2025-12-04 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2025-12-04 | 8-K | Reg FD Disclosure, Other Events, Financial Statements & Exhibits | SEC |
| 2025-11-06 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-10-14 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-08-11 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-07-07 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-06-03 | 8-K | Material Agreement, Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2025-05-06 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-04-02 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-03-05 | 8-K | Reg FD Disclosure | SEC |
| 2025-02-27 | 8-K | Material Agreement, Termination of Agreement, Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-01-13 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-01-07 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-11-18 | 8-K | Charter Amendments | SEC |
| 2024-11-06 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-10-10 | 8-K | Reg FD Disclosure | SEC |
| 2024-08-01 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-05-31 | 8-K | Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2024-05-07 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-02-27 | 8-K | Material Agreement, Unregistered Sales, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-02-27 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-02-16 | 8-K | Reg FD Disclosure | SEC |
| 2024-01-08 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.